(Q43861966)

27 November 2017

title

Clinical advantages of amisulpride in the treatment of acute schizophrenia (English)

1 reference

27 November 2017

1 reference

T Burns

1

1 reference

27 November 2017

R Bale

series ordinal

2

1 reference

27 November 2017

publication date

1 November 2001

1 reference

Journal of International Medical Research

27 November 2017

published in

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

451-466

1 reference

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Positive vs. negative schizophrenia: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Treatment of negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Course types in schizophrenia: an analysis of European and American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Follow-up studies of schizophrenia I: Natural history and non-psychopathological predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Negative v positive schizophrenia. Definition and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

Risperidone in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900601

10.1177/147323000102900601

21 January 2018

Identifiers

DOI

1 reference

release_j7gmz4mccnc4ljwkfcnbfods54

27 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j7gmz4mccnc4ljwkfcnbfods54

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference